SYVC — Synovics Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $6.84m
- $25.96m
Annual cashflow statement for Synovics Pharmaceuticals, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2004 October 31st | 2005 October 31st | 2006 October 31st | C2007 October 31st | 2008 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.12 | -2.91 | -8.57 | -20.9 | -4.01 |
| Depreciation | |||||
| Non-Cash Items | 0.489 | 0.489 | 2.19 | 12.9 | 6.84 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.036 | 0.131 | 1.09 | 4.98 | 0.42 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.64 | -2.26 | -5.17 | -2.41 | 3.86 |
| Capital Expenditures | -0.013 | -0.238 | -1.59 | -0.71 | -0.708 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.112 | -8.8 | 0 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.013 | -0.35 | -10.4 | -0.71 | -0.708 |
| Financing Cash Flow Items | 0 | 0 | -0.841 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.28 | 2.11 | 17.8 | 0.725 | -3.09 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.626 | -0.5 | 2.27 | -2.39 | 0.066 |